Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Non Operating Income (2016 - 2025)

Fortress Biotech (FBIO) has 12 years of Non Operating Income data on record, last reported at $17.7 million in Q3 2025.

  • For Q3 2025, Non Operating Income rose 1550.05% year-over-year to $17.7 million; the TTM value through Sep 2025 reached $32.4 million, up 1018.44%, while the annual FY2024 figure was -$10.2 million, 198.68% down from the prior year.
  • Non Operating Income reached $17.7 million in Q3 2025 per FBIO's latest filing, down from $24.8 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $24.8 million in Q2 2025 and bottomed at -$10.5 million in Q4 2022.
  • Average Non Operating Income over 5 years is $2.0 million, with a median of -$1.1 million recorded in 2023.
  • Peak YoY movement for Non Operating Income: crashed 601.9% in 2024, then soared 2495.66% in 2025.
  • A 5-year view of Non Operating Income shows it stood at -$6.0 million in 2021, then crashed by 74.81% to -$10.5 million in 2022, then soared by 89.54% to -$1.1 million in 2023, then plummeted by 601.9% to -$7.7 million in 2024, then soared by 328.26% to $17.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $17.7 million in Q3 2025, $24.8 million in Q2 2025, and -$2.4 million in Q1 2025.